Search results
Results from the WOW.Com Content Network
The Pharmaceuticals and Medical Devices Agency (独立行政法人医薬品医療機器総合機構, Dokuritsu-gyōsei hōjin iyakuhin-iryō-kiki-sōgō-kikō) (PhMDA ...
The Japanese Adverse Drug Event Report (JADER) database is a spontaneous reporting system of drug adverse events which is managed by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan. [1] It has been available since 2012. [1]
Sakigake (さきがけ, lit. "pathfinder", "harbinger") is a drug designation by the Pharmaceuticals and Medical Devices Agency, the pharmaceuticals regulator of Japan. It was designed to provide easier access to novel advanced treatments. [1]
PMDA may refer to: Pharmaceuticals and Medical Devices Agency , a Japanese governmental organization, similar in function to the Food and Drug Administration (FDA) in the US Plutonium Management and Disposition Agreement , an agreement between the United States and Russia signed in 2000
This article needs to be updated.The reason given is: there was a significant revision to Japan's Pharmaceuticals and Medical Devices Act (PMD Act) in December 4, 2019 (令和 元 年12月 4日) and certain articles in this revised PMD Act took effect April 1, 2020, September 1, 2020, and August 1, 2021; other articles will take effect Dec. 1, 2022 (see also: https://www.natlawreview.com ...
A Japanese Accepted Name (Japanese: 日本医薬品一般的名称, Hepburn: Nihon Iyakuhin Ippan-teki Meishō) (JAN) is the official non-proprietary or generic name given to a pharmaceutical substance by the Government of Japan. [1] [2]
Search engines, including web search engines, ... JobStreet.com (Southeast Asia, Japan, India ... Integrates with the main Google search engine page. As of September ...
The first Western compounding pharmacy was opened in Japan in 1872 by Arinobu Fukuhara operating under the name Shiseidō. 1893 Japan Pharmaceutical Association was established as the sole national professional association for pharmacists. [4] [2] In 1909, The Japan Pharmaceutical Association was legally incorporated as a public interest ...